Equities research analysts forecast that RedHill Biopharma Ltd. (NASDAQ:RDHL) will post earnings of ($0.40) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for RedHill Biopharma’s earnings. RedHill Biopharma posted earnings per share of ($0.70) in the same quarter last year, which would suggest a positive year […]
